Titre:
  • Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study
Auteur:Vachiery, Jean-Luc; Langley, Jonathan; Galie, Nazzareno; Hoeper, Marius M.; Peacock, Andrew J.; Sitbon, Olivier; Cheli, Martino; Church, Colin; Olsson, Karen K.M.; Palazzini, Massimiliano; Waterhouse, Brian
Informations sur la publication:The Journal of heart and lung transplantation, 36, 4, page (399-406)
Statut de publication:Publié, 2017-04
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:ambrisentan
post-authorisation safety study
pulmonary arterial hypertension
registry
safety
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1053-2498
info:doi/10.1016/j.healun.2016.04.013
info:pii/S1053249816301176
info:scp/84973135852